CRISPR-Edited Immune Effectors: The End of the Beginning

Feiyan Mo, Helen Heslop, Maksim Mamonkin

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)995-996
Number of pages2
JournalMolecular Therapy
Issue number4
StatePublished - Apr 8 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this